Mar 31, 2022 7:00am EDT Unicycive Announces Full Year 2021 Financial Results and Provides Business Update
Mar 16, 2022 8:37am EDT Unicycive Announces Acceptance of Two Preclinical Data Sets to be Presented at the European Renal Association Congress
Feb 02, 2022 7:00am EST Unicycive Announces Renazorb Pre-clinical and Clinical Data Selected for Presentation at National Kidney Foundation Spring Clinical Meeting
Jan 10, 2022 7:00am EST Unicycive Therapeutics to Present at the H.C. Wainwright BIOCONNECT Virtual Conference
Nov 29, 2021 7:00am EST Unicycive Therapeutics Receives Confirmatory Guidance on Renazorb Regulatory Pathway
Oct 26, 2021 7:30am EDT Unicycive Therapeutics Appoints Douglas Jermasek As Executive Vice President, Corporate Strategy
